Equity strategies

Carmignac Portfolio Grande Europe

Luxembourg SICAV sub-fundEuropean marketSRI Fund Article 9
Share Class

LU1623761951

A high conviction, sustainable European equity strategy
  • Rigorous stock screening combined with bottom-up fundamental analysis form the bedrock of the investment process.
  • On the lookout for long-term growth, built on robust fundamentals and strong business models.
Asset Allocation
Equities94.3 %
Other5.7 %
Data as of:  31 Jul 2024.
Risk Indicator
4/7
Recommended Minimum Investment Horizon
5 years
Cumulative Performance since launch
+ 96.0 %
0.0 %
+ 77.9 %
+ 9.7 %
+ 17.7 %
From 26/07/2017
To 29/08/2024
Calendar Year Performance 2023
-
-
-
+ 0.9 %
- 9.0 %
+ 37.8 %
+ 19.6 %
+ 22.5 %
- 20.6 %
+ 15.3 %
Net Asset Value
196.96 €
Asset Under Management
988 M €
Market
European market
SFDR - Fund Classification

Article

9
Data as of:  29 Aug 2024.
​Past performance is not necessarily indicative of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor). The return may increase or decrease as a result of currency fluctuations, for the shares which are not currency-hedged. The Sustainable Finance Disclosure Regulation (SFDR) 2019/2088 is a European regulation that requires asset managers to classify their funds as either 'Article 8' funds, which promote environmental and social characteristics, 'Article 9' funds, which make sustainable investments with measurable objectives, or 'Article 6' funds, which do not necessarily have a sustainability objective. For more information please refer to https://eur-lex.europa.eu/eli/reg/2019/2088/oj.

Carmignac Portfolio Grande Europe fund performance

Take a look at the Fund's performance supported by our Fund managers’ market commentary and strategy insight.

Our monthly comments

Data as of:  31 Jul 2024.
Fund management team
[Management Team] [Author] Denham Mark

Mark Denham

Head of Equities, Fund Manager

Market environment

  • In July, there was a significant stock market rotation, with the European market experiencing a decline.
  • Despite the ECB’s interest rate cuts in June, prompted by a gradual decline in inflation that has boosted optimism, European equities dipped as earnings in the Technology and Luxury goods sectors dragged on returns.
  • The technology sector was notably weak, influenced by negative sentiment from sharp declines in Tesla and other Magnificent Seven stocks in the US, while the demand in luxury goods especially in China weighed on results.

Performance commentary

  • During the month of July, the Fund recorded a positive absolute performance, though below its reference indicator.
  • The underperformance versus the benchmark last month is mainly due to the market rotation to small cap companies and the rally in Banks which we do not hold in our portfolio.
  • Lonza and Argenx have been the two best performers in the fund after both reported strong quarterly results and provided an optimistic outlook, which benefited the Fund.
  • Our biggest detractor during the month has been Novo Nordisk which experienced a significant decline during the month.
  • The decline was mainly due to the ongoing momentum unwind and news of competition from rival company Roche, who released early data on an oral GLP-1 product.
  • Having no exposure to Communication Services penalised the Fund while, on the contrary, having no exposure to Energy has been supportive.

Outlook strategy

  • During the month we have made several adjustments to our portfolio. We significantly reduced our holdings in high momentum stocks, including SAP, Schneider, ASML, and Novo Nordisk.
  • On the other hand, we made small additions to Healthcare stocks that have been underperforming recently, such as Straumann and Beiersdorf and Demant.
  • The Fund continues to rely on bottom-up fundamental analysis with a medium-long term horizon.
  • As rate cuts have started in Europe and the economies weaken, we are encouraged that markets should be able to ride out a period of weaker economic strength and some political headlines.
  • We stick to our process of focusing on profitable companies with high returns on capital, reinvesting for growth and maintain our focus on stocks and sectors with strong visibility on sales and profits.

Performance Overview

Data as of:  29 Aug 2024.
​Past performance is not necessarily indicative of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor). Morningstar Rating™ :  © Morningstar, Inc. All Rights Reserved. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.​From 01/01/2013 the equity index reference indicators are calculated net dividends reinvested. The return may increase or decrease as a result of currency fluctuations, for the shares which are not currency-hedged.
Source: Carmignac at 31/08/2024

Carmignac Portfolio Grande Europe Portfolio overview

Below is an overview of the composition of the portfolio.

Geographical Breakdown

Data as of:  31 Jul 2024.
Europe100.0 %
Total % Equities100.0 %
Europe100.0 %
frFrance
24.8 %
deGermany
22.6 %
dkDenmark
15.5 %
chSwitzerland
15.0 %
nlNetherlands
12.9 %
seSweden
4.8 %
ieIreland
3.0 %
esSpain
1.6 %

Key figures

Below are the key figures for the Fund, which will give you a clearer idea of the Fund's management and equity positioning.

Exposure Data

Data as of:  31 Jul 2024.
Equity Investment Weight94.3 %
Net Equity Exposure94.3 %
Number of Equity Issuers36
Active Share82.9 %

The strategy in a nutshell

Discover the Fund’s main features and benefits through the words of the Fund Manager.
Fund Management Team
[Management Team] [Author] Denham Mark

Mark Denham

Head of Equities, Fund Manager
In our approach to European equities, we focus on sustainable high-quality companies which demonstrate high levels of profitability while favouring profits reinvestment over profits distribution to grow the business for the future.
[Management Team] [Author] Denham Mark

Mark Denham

Head of Equities, Fund Manager
View Fund's characteristics
Reference to certain securities and financial instruments is for illustrative purposes to highlight stocks that are or have been included in the portfolios of funds in the Carmignac range. This is not intended to promote direct investment in those instruments, nor does it constitute investment advice. The Management Company is not subject to prohibition on trading in these instruments prior to issuing any communication. The portfolios of Carmignac funds may change without previous notice.
The reference to a ranking or prize, is no guarantee of the future results of the UCIS or the manager.
Carmignac Portfolio is a sub-fund of Carmignac Portfolio SICAV, an investment company under Luxembourg law, conforming to the UCITS Directive.
The information presented above is not contractually binding and does not constitute investment advice. Past performance is not a reliable indicator of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor), where applicable. Investors may lose some or all of their capital, as the capital in the UCI is not guaranteed. Access to the products and services presented herein may be restricted for some individuals or countries. Taxation depends on the situation of the individual. The risks, fees and recommended investment period for the UCI presented are detailed in the KIDs (key information documents) and prospectuses available on this website. The KID must be made available to the subscriber prior to purchase.). The reference to a ranking or prize, is no guarantee of the future results of the UCITS or the manager.

Related articles

Sustainable investing10 July 2024English

Carmignac’s Article 9 funds: a sustainable investment?

3 minute(s) read
Find out more